Verrica Pharmaceuticals Announces Agreement With Walgreens To Distribute YCANTH

RTTNews | Pred 356 dňami
Verrica Pharmaceuticals Announces Agreement With Walgreens To Distribute YCANTH

(RTTNews) - Dermatology therapeutics company Verrica Pharmaceuticals Inc. (VRCA) announced Wednesday the expansion of its distribution network by entering into an agreement with Walgreen Co., a subsidiary of Walgreens Boots Alliance, Inc. (WBA), to distribute YCANTH through its specialty pharmacy.

Walgreens joins Verrica's existing specialty pharmacy, Nufactor, who continues to be instrumental in helping the Company build awareness of YCANTH therapy among high volume dermatology and pediatric medical practices.

YCANTH is the first FDA-approved therapy for the treatment of molluscum contagiosum.

read more
Walgreens To Close 1,200 US Stores

Walgreens To Close 1,200 US Stores

Walgreens announced its plan to close around 1,200 U.S stores over the next three years, including around 500 closures in fiscal 2025, as the drug store chain is facing a challenging U.S. retail environment amid increasing competition. The move, which was announced while reporting a significantly wider net loss in its fourth quarter, is expected to be immediately accretive to adjusted earnings...
RTTNews | Pred 69 dňami
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | Pred 295 dňami
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews | Pred 469 dňami
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians. The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.
RTTNews | Pred 469 dňami
Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

While reporting financial results for the third quarter on Tuesday, Walgreens Boots Alliance, Inc. (WBA) slashed its adjusted earnings guidance for the full-year 2023 to a range of $4.00 to $4.05 per share from the prior forecast range of $4.45 to $4.65 per share, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.
RTTNews | Pred 546 dňami
Walgreens, CVS Reportedly Plan To Offer Abortion Pills

Walgreens, CVS Reportedly Plan To Offer Abortion Pills

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. are planning to offer abortion pills after the U.S. Food and Drug Administration decided to allow retail pharmacies to sell the product in the United States, reports said. On Tuesday, the agency announced a regulatory change allowing mifepristone, which is used in first-trimester abortions, to be dispensed by retail pharmacies.
RTTNews | Pred 719 dňami